News: Uroplasty Inc (UPI.OQ)
UPI.OQ on NASDAQ Stock Exchange Capital Market
2.28USD
1 Aug 2013
2.28USD
1 Aug 2013
Price Change (% chg)
$0.01 (+0.44%)
$0.01 (+0.44%)
Prev Close
$2.27
$2.27
Open
$2.25
$2.25
Day's High
$2.29
$2.29
Day's Low
$2.24
$2.24
Volume
600
600
Avg. Vol
19,949
19,949
52-wk High
$4.32
$4.32
52-wk Low
$1.69
$1.69
Select another date:
Fri, Jun 14 2013
Uroplasty places CFO on leave, delays filing annual report
- Medical device maker Uroplasty Inc said it placed Chief Financial Officer Mahedi Jiwani on administrative leave pending a review of internal financial controls, and would delay filing its annual report for the year ended March 31.
Select another date:
- Uroplasty's CEO Discusses F1Q14 Results - Earnings Call Transcript
- Uroplasty's CEO Discusses F4Q 2013 Results - Earnings Call Transcript
- Can Uroplasty Drive Adoption Of Its Better Mousetrap?
- 6 Small Caps Trading Near 52-Week Lows
- 20 Micro-Cap Stocks Being Snapped Up By Hedge Funds
- 17 High-Growth Healthcare Stocks Being Bought Up By Hedge Funds
Press Releases
- Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Uroplasty, Inc.
- Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Uroplasty, Inc.
- Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Uroplasty, Inc.
- Law Offices of Todd M. Garber Announces Investigation of Uroplasty, Inc.
- INVESTOR NOTICE: Rosen Law Firm Announces Class Action On Behalf of Uroplasty, Inc. Investors – UPI
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Uroplasty, Inc.
- Glancy Binkow & Goldberg LLP Announces Investigation of Uroplasty, Inc.
- Law Firm Finkelstein Thompson LLP Announces Investigation of UPI Inc.
- Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Uroplasty, Inc.
- Study Demonstrates Percutaneous Tibial Nerve Stimulation Offers More Cost-Effective OAB Treatment Than Sacral Nerve Stimulation

